CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL$10.56B
Large CapNASDAQServices-Commercial Physical & Biological ResearchPharmaceuticals🇺🇸North AmericaWILMINGTON20.1K employees
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 5, 2026
7wMarket Overview
Stock performance and key metrics
CRL News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply